Our Latest News

Thu Jun 07 00:00:00 EDT 2018

DePuy Synthes Launches Innovative Nailing System Aimed at Improving Treatment of Femoral Shaft Fractures in the U.S.

West Chester, PA – June 7, 2018 – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the U.S. launch of its Femoral Recon Nail System, a nailing system that provides new options for the surgical treatment of a wide variety of long thigh bone fractures. This new system builds on the company’s comprehensive trauma portfolio of innovative solutions designed to improve outcomes for patients with hip and femur fractures.

Tue May 22 00:00:00 EDT 2018

New GLOBAL UNITE Reverse Fracture Shoulder Implant from DePuy Synthes Addresses Unmet Needs in Complex Shoulder Fractures

MAY 22, 2018 Warsaw, IN – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the U.S. launch of the GLOBAL UNITE Reverse Fracture Shoulder, an innovative implant solution for shoulder reconstruction following complex fractures in patients with a grossly deficient rotator cuff. The new system is designed to provide increased flexibility for securely reattaching the bone to the implant, which is important for healing and function, and allowing biological fixation to the stem of the implant with a porous coating to help deliver a consistent surgical outcome. This new offering adds to DePuy Synthes’ commitment to innovative shoulder solutions that address the full continuum of shoulder disorders.

Thu May 10 00:00:00 EDT 2018

ATTUNE Knee System Linked to Improvements in Patient Quality of Life and Reduced Length of Hospital Stay

Warsaw, Indiana, May 10, 2018: DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announced clinical findings outlining the potential benefits patients may experience when undergoing knee replacement with the ATTUNE Knee System.

Wed May 09 00:00:00 EDT 2018

DePuy Synthes Announces Agreement with Prosidyan to Exclusively Promote FIBERGRAFT® Family of Products for Spine Fusion Surgery

RAYNHAM, Mass. – May 9, 2018 – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announced an exclusive agreement in the U.S. between DePuy Synthes Sales, Inc. and Prosidyan to promote the FIBERGRAFT® Family of Products, a line of synthetic bone graft materials which are ultra-porous, designed for ease of use, and have been engineered for optimal resorption in clinical use during spine fusion surgery. By adding FIBERGRAFT to its offerings, DePuy Synthes will further enhance the company’s biomaterials portfolio for spine, which currently includes cellular allograft, demineralized bone matrix and first generation synthetic solutions. Surgeons will now have a broad range of handling options based on the needs of each patient and surgical case.

Mon Apr 30 00:00:00 EDT 2018

CORAIL STANDARD COLLARED FEMORAL STEM DEMONSTRATES A 29% LOWER REVISION RISK COMPARED TO CLASS, ACCORDING TO INDEPENDENT JOINT REGISTRY ANALYSIS

WARSAW, Indiana (April 30) -- DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, announced today clinical results associated with the use of its CORAIL Hip System Femoral Stems. Results showed that both the collarless and collared versions of the CORAIL Cementless Stem performed in line with industry expectations and that the CORAIL Standard Collared stem was associated with a 29% lower revision risk when compared to all other cementless stems on the National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man.1,2 This analysis was independently conducted based on NJR data.

Thu Apr 26 00:00:00 EDT 2018

New PROTI 360° Family of Implants from DePuy Synthes Is Designed to Enhance Spinal Fusion Surgery Outcomes

Raynham, MA - April 26, 2018 – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the U.S. launch of the PROTI 360° Integrated Titanium Family of interbody devices to advance care for patients who have degenerative disc disease in the neck and back. This new offering underscores the commitment of DePuy Synthes to expand the company’s portfolio of interbody fusion devices designed to help improve outcomes after spinal fusion surgery.